Related references
Note: Only part of the references are listed.A novel, topical, nonsteroidal, TRPV1 antagonist, PAC-14028 cream improves skin barrier function and exerts anti-inflammatory action through modulating epidermal differentiation markers and suppressing Th2 cytokines in atopic dermatitis
Ji-Hae Lee et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2018)
Emerging therapies for atopic dermatitis: TRPV1 antagonists
Jonathan G. Bonchak et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Emerging therapies for atopic dermatitis: JAK inhibitors
David G. Cotter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Therapeutic pipeline for atopic dermatitis: End of the drought?
Amy S. Paller et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Atopic Dermatitis in Adults: A Diagnostic Challenge
Silvestre J. F. Salvador et al.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2017)
Emerging Treatment Options in Atopic Dermatitis: Topical Therapies
Uffe Nygaard et al.
DERMATOLOGY (2017)
Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults
Amy S. Paller et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Self-maintenance of neurogenic inflammation contributes to a vicious cycle in skin
Olivier Gouin et al.
EXPERIMENTAL DERMATOLOGY (2015)
A comparison of radio-frequency biomotion sensors and actigraphy versus polysomnography for the assessment of sleep in normal subjects
Emer O'Hare et al.
SLEEP AND BREATHING (2015)
A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1
Ferda Cevikbas et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Mast cell activation contributes to sickle cell pathobiology and pain in mice
Lucile Vincent et al.
BLOOD (2013)
Itch and Pain in Adolescents are Associated with Suicidal Ideation: A Population-based Cross-sectional Study
Jon Anders Halvorsen et al.
ACTA DERMATO-VENEREOLOGICA (2012)
Development of PAC-14028, a Novel Transient Receptor Potential Vanilloid Type 1 (TRPV1) Channel Antagonist as a New Drug for Refractory Skin Diseases
Kyung-Min Lim et al.
ARCHIVES OF PHARMACAL RESEARCH (2012)
Antipruritic Effects of TRPV1 Antagonist in Murine Atopic Dermatitis and Itching Models
Jun-Won Yun et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Management of Itch in Atopic Dermatitis
Judith Hong et al.
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2011)
TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms
Noritaka Imamachi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mechanisms of disease: Atopic dermatitis
Thomas Bieber
NEW ENGLAND JOURNAL OF MEDICINE (2008)
TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase
Won-Sik Shim et al.
JOURNAL OF NEUROSCIENCE (2007)
Neuronal control of skin function: The skin as a neuroimmunoendocrine organ
Dirk Roosterman et al.
PHYSIOLOGICAL REVIEWS (2006)
A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases
PE Beattie et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis
MS Chapman et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents
LF Eichenfield et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis
JM Hanifin et al.
EXPERIMENTAL DERMATOLOGY (2001)
Share Paper
